Product NDC: | 62207-753 |
Proprietary Name: | Naproxen Sodium |
Non Proprietary Name: | Naproxen Sodium |
Active Ingredient(s): | 220 mg/1 & nbsp; Naproxen Sodium |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 62207-753 |
Labeler Name: | Granules India Limited |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | ANDA091353 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110930 |
Package NDC: | 62207-753-43 |
Package Description: | 43 TABLET in 1 BOTTLE (62207-753-43) |
NDC Code | 62207-753-43 |
Proprietary Name | Naproxen Sodium |
Package Description | 43 TABLET in 1 BOTTLE (62207-753-43) |
Product NDC | 62207-753 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Naproxen Sodium |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20110930 |
Marketing Category Name | ANDA |
Labeler Name | Granules India Limited |
Substance Name | NAPROXEN SODIUM |
Strength Number | 220 |
Strength Unit | mg/1 |
Pharmaceutical Classes |